Net profit of Sandu Pharmaceuticals rose 75.00% to Rs 0.98 crore in the quarter ended December 2025 as against Rs 0.56 crore during the previous quarter ended December 2024. Sales rose 2.12% to Rs 18.76 crore in the quarter ended December 2025 as against Rs 18.37 crore during the previous quarter ended December 2024.
| Particulars | Quarter Ended |
| Dec. 2025 | Dec. 2024 | % Var. |
| Sales | 18.76 | 18.37 | 2 |
| OPM % | 5.60 | 5.44 | - |
| PBDT | 1.03 | 0.99 | 4 |
| PBT | 0.86 | 0.80 | 8 |
| NP | 0.98 | 0.56 | 75 |